Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). In 2021, U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tvmh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to blindness.
The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
The global Plasminogen market is projected to reach US$ 64 million in 2029, increasing from US$ 7 million in 2022, with the CAGR of 39.5% during the period of 2023 to 2029.
Global Plasminogen key players include Kedrion(Prometic), etc. North America is the largest market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasminogen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Kedrion(Prometic)
Segment by Type
Intravenous Injection
Eye Drops
Segment by Application
Ligneous Conjunctivitis
Diabetic Foot
Wound Healing
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plasminogen report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Plasminogen Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Plasminogen
1.2 Plasminogen Segment by Type
1.2.1 Global Plasminogen Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Intravenous Injection
1.2.3 Eye Drops
1.3 Plasminogen Segment by Application
1.3.1 Global Plasminogen Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Ligneous Conjunctivitis
1.3.3 Diabetic Foot
1.3.4 Wound Healing
1.3.5 Others
1.4 Global Plasminogen Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Plasminogen Revenue 2018-2029
1.4.2 Global Plasminogen Sales 2018-2029
1.4.3 Global Plasminogen Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Plasminogen Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Plasminogen Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Plasminogen Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Plasminogen Average Price by Manufacturers (2018-2023)
2.4 Global Plasminogen Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Plasminogen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasminogen, Product Type & Application
2.7 Plasminogen Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Plasminogen Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasminogen Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Plasminogen Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasminogen Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Plasminogen Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Plasminogen Global Plasminogen Sales by Region: 2018-2029
3.2.1 Global Plasminogen Sales by Region: 2018-2023
3.2.2 Global Plasminogen Sales by Region: 2024-2029
3.3 Global Plasminogen Global Plasminogen Revenue by Region: 2018-2029
3.3.1 Global Plasminogen Revenue by Region: 2018-2023
3.3.2 Global Plasminogen Revenue by Region: 2024-2029
3.4 North America Plasminogen Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Plasminogen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Plasminogen Sales by Country (2018-2029)
3.4.3 North America Plasminogen Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plasminogen Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Plasminogen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Plasminogen Sales by Country (2018-2029)
3.5.3 Europe Plasminogen Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasminogen Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Plasminogen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Plasminogen Sales by Country (2018-2029)
3.6.3 Asia Pacific Plasminogen Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasminogen Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Plasminogen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Plasminogen Sales by Country (2018-2029)
3.7.3 Latin America Plasminogen Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasminogen Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Plasminogen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Plasminogen Sales by Country (2018-2029)
3.8.3 Middle East and Africa Plasminogen Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasminogen Sales by Type (2018-2029)
4.1.1 Global Plasminogen Sales by Type (2018-2023)
4.1.2 Global Plasminogen Sales by Type (2024-2029)
4.1.3 Global Plasminogen Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Plasminogen Revenue by Type (2018-2029)
4.2.1 Global Plasminogen Revenue by Type (2018-2023)
4.2.2 Global Plasminogen Revenue by Type (2024-2029)
4.2.3 Global Plasminogen Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Plasminogen Price by Type (2018-2029)
5 Segment by Application
5.1 Global Plasminogen Sales by Application (2018-2029)
5.1.1 Global Plasminogen Sales by Application (2018-2023)
5.1.2 Global Plasminogen Sales by Application (2024-2029)
5.1.3 Global Plasminogen Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Plasminogen Revenue by Application (2018-2029)
5.2.1 Global Plasminogen Revenue by Application (2018-2023)
5.2.2 Global Plasminogen Revenue by Application (2024-2029)
5.2.3 Global Plasminogen Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Plasminogen Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Kedrion(Prometic)
6.1.1 Kedrion(Prometic) Corporation Information
6.1.2 Kedrion(Prometic) Description and Business Overview
6.1.3 Kedrion(Prometic) Plasminogen Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Kedrion(Prometic) Plasminogen Product Portfolio
6.1.5 Kedrion(Prometic) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasminogen Industry Chain Analysis
7.2 Plasminogen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasminogen Production Mode & Process
7.4 Plasminogen Sales and Âé¶¹Ô´´ing
7.4.1 Plasminogen Sales Channels
7.4.2 Plasminogen Distributors
7.5 Plasminogen Customers
8 Plasminogen Âé¶¹Ô´´ Dynamics
8.1 Plasminogen Industry Trends
8.2 Plasminogen Âé¶¹Ô´´ Drivers
8.3 Plasminogen Âé¶¹Ô´´ Challenges
8.4 Plasminogen Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Kedrion(Prometic)
Ìý
Ìý
*If Applicable.